Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Preclinical pharmacology of metrifonate
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Preclinical pharmacology of metrifonate'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Pharmacology
100%
Metrifonate
100%
Acetylcholinesterase Inhibitors (AChEI)
50%
Acetylcholine
50%
Alzheimer's Disease
25%
Dose Effect
25%
Cholinergic Neurons
25%
Acetylcholinesterase
25%
Chronic Neurodegeneration
25%
Behavioral Deficits
25%
Cognitive Dysfunction
25%
Pharmacologic
25%
Aged Rats
25%
Young Rats
25%
Performance Improvement
25%
Activities of Daily Living
25%
Memory Impairment
25%
Short-acting
25%
Inhibitor-2
25%
Red Blood Cells
25%
Safety Test
25%
Behavioral Disturbances
25%
Acetylcholinesterase Inhibition
25%
Oxime
25%
Cognitive Improvement
25%
Dimethylallyl Diphosphate (DMAPP)
25%
Regeneration Times
25%
Pharmacology, Toxicology and Pharmaceutical Science
Metrifonate
100%
Preclinical Pharmacology
100%
Cholinesterase Inhibitor
50%
Acetylcholinesterase
50%
Acetylcholine
50%
Alzheimer's Disease
25%
Disease
25%
Cognitive Defect
25%
Cholinergic Receptor Stimulating Agent
25%
Memory Disorder
25%
Dichlorvos
25%
Vinylidene Chloride
25%
Behavior Disorder
25%
Oxime
25%
Safety Test
25%